Procaterol hydrochloride

This classification denotes an adrenergic beta-2 receptor agonist C16H22N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4VD1BRT7T8, chemically known as 2(1h)-quinolinone, 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-, monohydrochloride, (r*,s*), (+/-)-, but more generally known as procaterol hydrochloride, which bears US NIH Compound Identifier 43091. European Medicines Agency schedules Procaterol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04050MIG. Most nations, for tariff and trade purposes, schedule procaterol hydrochloride under HS 29337900 and SITC 51561. As of Q4 2014, PROCATEROL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC[C@H]([C@H](C1CCC(C2C1CCC(=O)[NH]2)O)O)NC(C)C.CL.